Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
Nautilus Biotechnology to report Q3 financial results on October 31, 2023
Positive
Nautilus Biotechnology will report its third quarter financial results on October 31, 2023. The company's management will discuss its results, business developments, and outlook in a webcast conference call.
10/11/2023 - 08:05 AM
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter before market open on Tuesday, October 31, 2023.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio .
About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio .
Media Contact press@nautilus.bio
Investor Contact investorrelations@nautilus.bio
When will Nautilus Biotechnology report its Q3 financial results?
Nautilus Biotechnology will report its third quarter financial results on October 31, 2023.
What will be discussed in the webcast conference call?
The company's management will discuss its results, business developments, and outlook.
Where can I listen to the webcast?
The webcast will be available on the 'Investors' section of the company website at www.nautilus.bio.
Nautilus Biotechnology Inc
NAUT Rankings
#2135 Ranked by Stock Gains
NAUT Stock Data
Industry
Analytical Laboratory Instrument Manufacturing
Sector
Manufacturing
About NAUT
born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.